These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35113934)

  • 1. In vivo interferon-gamma induced changes in gene expression dramatically alter neutrophil phenotype.
    Ambruso DR; Briones NJ; Baroffio AF; Murphy JR; Tran AD; Gowan K; Sanford B; Ellison M; Jones KL
    PLoS One; 2022; 17(2):e0263370. PubMed ID: 35113934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependent enhancements by interferon-gamma on functional responses of neutrophils from chronic granulomatous disease patients.
    Ahlin A; Elinder G; Palmblad J
    Blood; 1997 May; 89(9):3396-401. PubMed ID: 9129047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-γ alters the expression of diverse immunity related genes in a cell culture model designed to represent maturing neutrophils.
    Ellison MA; Gearheart CM; Porter CC; Ambruso DR
    PLoS One; 2017; 12(10):e0185956. PubMed ID: 28982143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease.
    Ezekowitz RA; Orkin SH; Newburger PE
    J Clin Invest; 1987 Oct; 80(4):1009-16. PubMed ID: 2821069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged recombinant interferon-gamma therapy in chronic granulomatous disease: evidence against enhanced neutrophil oxidase activity.
    Woodman RC; Erickson RW; Rae J; Jaffe HS; Curnutte JT
    Blood; 1992 Mar; 79(6):1558-62. PubMed ID: 1312372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and molecular effects of recombinant interferon gamma in chronic granulomatous disease.
    Newburger PE; Ezekowitz RA
    Hematol Oncol Clin North Am; 1988 Jun; 2(2):267-76. PubMed ID: 2839459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved superoxide-generating ability by interferon gamma due to splicing pattern change of transcripts in neutrophils from patients with a splice site mutation in CYBB gene.
    Ishibashi F; Mizukami T; Kanegasaki S; Motoda L; Kakinuma R; Endo F; Nunoi H
    Blood; 2001 Jul; 98(2):436-41. PubMed ID: 11435314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma interferon treatment of patients with chronic granulomatous disease is associated with augmented production of nitric oxide by polymorphonuclear neutrophils.
    Ahlin A; Lärfars G; Elinder G; Palmblad J; Gyllenhammar H
    Clin Diagn Lab Immunol; 1999 May; 6(3):420-4. PubMed ID: 10225847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased production of nitric oxide by neutrophils from patients with chronic granulomatous disease on interferon-gamma treatment.
    Naderi beni F; Fattahi F; Mirshafiey A; Ansari M; Mohsenzadegan M; Movahedi M; Pourpak Z; Moin M
    Int Immunopharmacol; 2012 Apr; 12(4):689-93. PubMed ID: 22330085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of interferon-gamma, in vitro and in vivo, on mRNA levels of phagocyte oxidase components.
    Weening RS; de Klein A; de Boer M; Roos D
    J Leukoc Biol; 1996 Dec; 60(6):716-20. PubMed ID: 8975873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-γ targets macrophage-mediated immune responses toward
    Greenlee-Wacker MC; Nauseef WM
    J Leukoc Biol; 2017 Mar; 101(3):751-758. PubMed ID: 27707882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression in chronic granulomatous disease and interferon-γ receptor-deficient cells treated in vitro with interferon-γ.
    Frazão JB; Colombo M; Simillion C; Bilican A; Keller I; Wüthrich D; Zhu Z; Okoniewski MJ; Bruggmann R; Condino-Neto A; Newburger PE
    J Cell Biochem; 2019 Mar; 120(3):4321-4332. PubMed ID: 30260027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the IFN-gamma-induced enhancement of superoxide production in CGD-phagocytes caused by increased expression of the p47-phox cytosolic protein.
    Jendrossek V; Damm U; Liese J; Belohradsky BH; Gahr M
    Immunodeficiency; 1993; 4(1-4):187-90. PubMed ID: 8167697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous Host-Pathogen Transcriptome Analysis during Granulibacter bethesdensis Infection of Neutrophils from Healthy Subjects and Patients with Chronic Granulomatous Disease.
    Greenberg DE; Sturdevant DE; Marshall-Batty KR; Chu J; Pettinato AM; Virtaneva K; Lane J; Geller BL; Porcella SF; Gallin JI; Holland SM; Zarember KA
    Infect Immun; 2015 Nov; 83(11):4277-92. PubMed ID: 26283340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo activation of peripheral blood polymorphonuclear neutrophils by gamma interferon results in enhanced fungal killing.
    Morrison CJ; Brummer E; Stevens DA
    Infect Immun; 1989 Oct; 57(10):2953-8. PubMed ID: 2550367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced generation of reactive oxygen species by interferon-γ may have contributed to successful treatment of invasive pulmonary aspergillosis in a patient with chronic granulomatous disease.
    Yamashita K; Miyoshi T; Arai Y; Mizugishi K; Takaori-Kondo A; Ueyama T
    Int J Hematol; 2013 Apr; 97(4):505-10. PubMed ID: 23526099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis of interferon-gamma and lipopolysaccharide enhancement of phagocyte respiratory burst capability. Studies on the gene expression of several NADPH oxidase components.
    Cassatella MA; Bazzoni F; Flynn RM; Dusi S; Trinchieri G; Rossi F
    J Biol Chem; 1990 Nov; 265(33):20241-6. PubMed ID: 2173701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus.
    Morgenstern DE; Gifford MA; Li LL; Doerschuk CM; Dinauer MC
    J Exp Med; 1997 Jan; 185(2):207-18. PubMed ID: 9016870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of innate immune receptors on neutrophils in chronic granulomatous disease.
    Hartl D; Lehmann N; Hoffmann F; Jansson A; Hector A; Notheis G; Roos D; Belohradsky BH; Wintergerst U
    J Allergy Clin Immunol; 2008 Feb; 121(2):375-382.e9. PubMed ID: 18155283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intersecting Stories of the Phagocyte NADPH Oxidase and Chronic Granulomatous Disease.
    Nauseef WM; Clark RA
    Methods Mol Biol; 2019; 1982():3-16. PubMed ID: 31172463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.